Good News for Roche (LLY) (RHHBY)
Roche Holdings Ltd. ( RHHBY ) announced that the Committee for Medicinal Products for Human Use (CHMP) recommended the approval of Avastin (bevacizumab) in combination with standard chemotherapy (carboplatin and paclitaxel), as a front-line treatment for advanced ovarian cancer. The final decision from the European Commission is expected later in 2011 […]